Scholar Rock opened lower at $45.39, compared with its previous close of $46.60. In the last trading session, the stock traded between $43.18 and $45.70. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Scholar Rock is now worth
$ 125.02
Giving a profit of
$ 25.02 (25.02%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 15 Analysts
Buy
93.33%
Hold
6.67%
Sell
0%
Markets Today
Today's Change
$-3.37 (-7.23%)
Day High
$45.70
Day Low
$43.18
Day Open
$45.39
Prev Close
$46.60
Volume
7,45,085
1W Return
-6.16%
1M Return
3.00%
3M Return
-16.97%
6M Return
-10.59%
1Y Return
40.41%
Fundamentals
Market Cap ($ Mn)
5,274
PE Ratio
-
PB Ratio
27.70
PEG Ratio
-
ROE
-134.52%
ROCE
-107.76%
EPS (TTM)
$-0.88
Investment Returns
1 Week
-6.16%
1 Month
3.00%
3 Months
-16.97%
6 Months
-10.59%
9 Months
-8.29%
Financials
Quarterly
All values in $ Mn
0.0
Mar 25
0.0
Jun 25
0.0
Sep 25
0.0
Dec 25
0.0
Jun 26
0.6
Sep 26
Updates
12Nov
Wolfe Research downgrades Scholar Rock Holding to Peer Perform
Wolfe Research downgraded Scholar Rock Holding to Peer Perform. Analyst Kalpit Patel revised the rating from Outperform. The change reflects a neutral stance relative to sector peers.
Today
20Oct
Scholar Rock to report Q3 2026 financial results on November 10
Scholar Rock Holding Corporation will report Q3 2026 results on November 10, 2026. Conference call scheduled for 8:00 am ET on the same day. Webcast replay available for approximately 90 days post-event. Company commercializing ISEMBLYD in the U.S. following September 2026 approval.
23 days ago
17Oct
Scholar Rock grants 61,020 shares in inducement awards to new hires
Granted inducement equity awards covering 61,020 shares to seven new hires. Included options for 17,461 shares at $41.94 exercise price and RSUs for 43,559 shares. Options vest 25% after one year, with remaining 75% over three years quarterly. Awards issued under Nasdaq Listing Rule 5635(c)(4) for non-employees.
27 days ago
21Sep
Scholar Rock grants 83,102 inducement shares to 10 new hires
Scholar Rock granted 83,102 inducement shares to 10 new employees. Awards include 23,801 stock options and 59,301 restricted stock units. Stock option exercise price set at $51.85 per share. Grants comply with Nasdaq Listing Rule 5635(c)(4).
1mo ago
14Sep
Scholar Rock shares rise as FDA approves first muscle-targeted SMA treatment
FDA approves ISEMBYLD as first muscle-targeted SMA treatment for patients aged 2+. Scholar Rock receives Rare Pediatric Disease Priority Review Voucher alongside approval. Phase 3 data shows 2.2-point HFMSE improvement vs control group at one year. SRRK shares rise 6.48% to $59.00 in pre-market trading.
1mo ago
2Sep
Scholar Rock wins FDA fast track for apitegromab in FSHD treatment
FDA grants Fast Track and Orphan Drug designations to apitegromab for FSHD. Participant dosing underway in Phase 2 FORGE clinical trial. Apitegromab is a monoclonal antibody inhibiting myostatin activation.
